| $687M | ||
| $385M | ||
| $215M | ||
| $100M | ||
| $87M | ||
| $82M |
Buys | $0 | 0 | 0 |
Sells | $6,409,693 | 45 | 100 |
| Freund John Gordon | director | 0 | $0 | 1 | $193,998 | $-193,998 |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | 0 | $0 | 5 | $219,774 | $-219,774 |
| RECUPERO ANTHONY J | President, Commercial Ops | 0 | $0 | 7 | $527,236 | $-527,236 |
| Maheshwari Anshul | Chief Financial Officer | 0 | $0 | 14 | $1.44M | $-1.44M |
| DUNN JEFFREY W | director | 0 | $0 | 8 | $1.58M | $-1.58M |
| FRANCIS LAURA | Chief Executive Officer | 0 | $0 | 9 | $2.38M | $-2.38M |
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Over the last 12 months, insiders at SI-BONE, Inc. have bought $0 and sold $6.41M worth of SI-BONE, Inc. stock.
On average, over the past 5 years, insiders at SI-BONE, Inc. have bought $0 and sold $13.77M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 400,000 shares for transaction amount of $6M was made by Bonita David P (director) on 2018‑10‑19.
| 2025-12-08 | Sale | DUNN JEFFREY W | director | 20,000 0.0469% | $19.33 | $386,594 | -2.17% | |
| 2025-11-25 | Sale | Maheshwari Anshul | Chief Financial Officer | 100 0.0002% | $20.00 | $2,000 | -3.06% | |
| 2025-11-24 | Sale | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | 400 0.0009% | $20.00 | $8,000 | -1.75% | |
| 2025-11-21 | Sale | Maheshwari Anshul | Chief Financial Officer | 1,200 0.0028% | $20.01 | $24,016 | -1.64% | |
| 2025-11-18 | Sale | FRANCIS LAURA | Chief Executive Officer | 5,411 0.012% | $17.70 | $95,763 | +4.30% | |
| 2025-11-17 | Sale | FRANCIS LAURA | Chief Executive Officer | 11,341 0.0254% | $17.43 | $197,622 | +6.78% | |
| 2025-11-17 | Sale | RECUPERO ANTHONY J | President, Commercial Ops | 3,833 0.0086% | $17.44 | $66,832 | +6.78% | |
| 2025-11-17 | Sale | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | 3,328 0.0075% | $17.41 | $57,934 | +6.78% | |
| 2025-11-17 | Sale | Maheshwari Anshul | Chief Financial Officer | 3,460 0.0078% | $17.43 | $60,297 | +6.78% | |
| 2025-11-11 | Sale | FRANCIS LAURA | Chief Executive Officer | 5,411 0.0136% | $17.06 | $92,307 | +4.80% | |
| 2025-11-11 | Sale | Maheshwari Anshul | Chief Financial Officer | 2,601 0.007% | $18.33 | $47,685 | +4.80% | |
| 2025-11-11 | Sale | DUNN JEFFREY W | director | 56,852 0.1584% | $18.95 | $1.08M | +4.80% | |
| 2025-11-03 | Sale | DUNN JEFFREY W | director | 293 0.0007% | $14.80 | $4,338 | +24.12% | |
| 2025-10-02 | Sale | RECUPERO ANTHONY J | President, Commercial Ops | 3,311 0.0074% | $14.25 | $47,197 | +10.03% | |
| 2025-10-02 | Sale | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | 3,128 0.007% | $14.25 | $44,583 | +10.03% | |
| 2025-10-02 | Sale | Maheshwari Anshul | Chief Financial Officer | 3,311 0.0074% | $14.20 | $47,013 | +10.03% | |
| 2025-08-18 | Sale | FRANCIS LAURA | Chief Executive Officer | 11,343 0.0264% | $15.60 | $176,940 | +0.84% | |
| 2025-08-18 | Sale | RECUPERO ANTHONY J | President, Commercial Ops | 3,833 0.0089% | $15.62 | $59,875 | +0.84% | |
| 2025-08-18 | Sale | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | 3,329 0.0078% | $15.64 | $52,055 | +0.84% | |
| 2025-08-18 | Sale | Maheshwari Anshul | Chief Financial Officer | 3,461 0.008% | $15.57 | $53,881 | +0.84% |
| FRANCIS LAURA | Chief Executive Officer | 351319 0.8097% | $6.53M | 0 | 49 | |
| RECUPERO ANTHONY J | President, Commercial Ops | 268144 0.618% | $4.98M | 0 | 81 | |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | 251496 0.5796% | $4.67M | 0 | 43 | |
| Maheshwari Anshul | Chief Financial Officer | 203773 0.4696% | $3.79M | 0 | 34 | |
| Freund John Gordon | director | 91767 0.2115% | $1.71M | 1 | 24 | <0.0001% |
| DUNN JEFFREY W | director | 10307 0.0238% | $191,504.06 | 0 | 80 | |
| Skyline Venture Partners V LP | 10 percent owner | 2819985 6.4993% | $52.4M | 1 | 7 | <0.0001% |
| Petersen Timothy | director | 1695036 3.9066% | $31.49M | 1 | 0 | <0.0001% |
| Montreux Equity Partners IV, L.P. | 10 percent owner | 1102915 2.5419% | $20.49M | 0 | 1 | |
| ORBIMED ADVISORS LLC | director | 985368 2.271% | $18.31M | 1 | 0 | <0.0001% |
| Bonita David P | director | 985368 2.271% | $18.31M | 1 | 0 | <0.0001% |
| Reiley Mark A | director | 513180 1.1827% | $9.53M | 0 | 1 | |
| HINCKLEY GREGORY K | director | 71394 0.1645% | $1.33M | 0 | 1 | |
| Reckling W Carlton | CMO and VP, Medical Affairs | 44170 0.1018% | $820,678.60 | 0 | 12 | |
| Davis Timothy E JR | director | 22361 0.0515% | $415,467.38 | 0 | 1 | |
| Nishimura Mika | director | 19350 0.0446% | $359,523.00 | 0 | 1 | |
| HILLEMAN JERYL L | director | 15349 0.0354% | $285,184.42 | 0 | 4 | |
| Yerby Scott A | Chief Technology Officer | 9284 0.0214% | $172,496.72 | 0 | 22 | |
| Licitra Karen A | director | 8797 0.0203% | $163,448.26 | 0 | 1 |
| Increased Positions | 86 | +43.43% | 5M | +12.49% |
| Decreased Positions | 86 | -43.43% | 4M | -9.63% |
| New Positions | 21 | New | 1M | New |
| Sold Out Positions | 22 | Sold Out | 946,848 | Sold Out |
| Total Postitions | 198 | 0% | 43M | +2.86% |
| Blackrock, Inc. | $67,997.00 | 8.04% | 3.46M | -14,382 | -0.41% | 2025-09-30 |
| American Century Companies Inc | $55,854.00 | 6.6% | 2.84M | +521,683 | +22.52% | 2025-09-30 |
| Brown Advisory Inc | $54,576.00 | 6.45% | 2.77M | -139,809 | -4.8% | 2025-09-30 |
| Orbimed Advisors Llc | $50,754.00 | 6% | 2.58M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $49,003.00 | 5.79% | 2.49M | +41,449 | +1.69% | 2025-09-30 |
| Champlain Investment Partners, Llc | $41,504.00 | 4.91% | 2.11M | -31,130 | -1.46% | 2025-09-30 |
| First Light Asset Management, Llc | $37,744.00 | 4.46% | 1.92M | +166,902 | +9.53% | 2025-09-30 |
| Silvercrest Asset Management Group Llc | $28,752.00 | 3.4% | 1.46M | -19,970 | -1.35% | 2025-09-30 |
| Nuveen, Llc | $26,621.00 | 3.15% | 1.35M | +147,114 | +12.2% | 2025-09-30 |
| Nuveen Asset Management, Llc | $24,875.00 | 2.94% | 1.26M | +190,830 | +17.78% | 2024-12-31 |